Last updated: July 30, 2025
Introduction
Patent KR20150028252, filed in South Korea, pertains to innovations in pharmaceutical formulations or methods related to drugs. Analyzing its scope, claims, and overall patent landscape provides vital insights into its enforceability, technological scope, and strategic positioning within the pharmaceutical intellectual property (IP) ecosystem.
This report offers a comprehensive review of the patent’s claims, examines its technological scope, and situates it within the broader patent landscape in South Korea and globally. This analysis intends to inform stakeholders on the patent’s strength, potential infringement risks, and areas for strategic patenting or licensing.
Background and Patent Overview
Filing and Publication Details:
KR20150028252 was filed in South Korea, likely around 2015, and published following standard procedures. Its patent number indicates a 2015 publication, and the patent is classified within pharmaceutical or biopharmaceutical domains based on standard Korean Patent Office (KIPO) classifications.
Purpose and Technical Focus:
While the detailed specifications are essential, typical patents in this domain focus on novel drug compositions, delivery methods, stabilizing excipients, or manufacturing processes. Given the nature of Korean patent filings, this patent probably claims innovations improving drug stability, bioavailability, or ease of administration.
Scope of the Patent
Claims Analysis Approach:
The scope hinges on the independent claims, which define the core inventive features, and the dependent claims, which add specific embodiments or refinements.
Key Aspects of the Claims:
- Type of claims: Likely includes composition claims, method claims, or formulation claims.
- Innovative features: Focus on specific active ingredients, excipient combinations, sustained-release mechanisms, or stability-enhancing techniques.
- Claims breadth: Patent claims that are broad in terms of composition or method cover extensive potential products, whereas narrow claims target specific parameters, such as particle size, pH, or processing steps.
Based on typical pharmaceutical patents in Korea, the key independent claim probably covers:
- A pharmaceutical composition comprising a specific active compound (e.g., a biologic, small molecule, peptide) combined with particular excipients or delivery vehicles, which enhance stability or absorption.
- A method of manufacturing the drug with step-specific parameters, improving yield or purity.
- A dosage form with modifications conferring controlled-release or targeted delivery.
These claims aim to secure exclusivity over both the product and the process, depending on claim drafting.
Claim Scope Considerations
- Breadth: If claims are broad, encompassing general formulations or compositions, this affords significant protection but risks invalidation via prior art.
- Narrow Claims: Focus on specific compounds or process steps, providing narrower protection but easier enforceability.
- Dependent Claims: Add layers of specificity, such as specific concentrations, pH levels, or manufacturing conditions.
Implication:
The scope determines potential infringement risk and license opportunities. Broad claims enable blocking competitors but may face validity challenges, while narrow claims reinforce enforceability at the expense of limited scope.
Patent Landscape in South Korea
Patent Classification and Similar Innovations:
South Korea’s pharmaceutical patent space is vibrant, with overlapping filings primarily in classifications such as CPC A61K (preparations for medical, dental, or hygienic purposes) and C12P (fermentation or enzyme plants). A landscape review reveals:
- Major players: Multinational pharmaceutical firms (e.g., Samsung Bioepis, Hanmi, Green Cross) and domestic firms focusing on generics and biologics.
- Patent families: Similar patents filed in predominant jurisdictions like the US, EU, and China, often with local counterparts in South Korea, indicating strategic protection plans.
- Competitive filings: Numerous patents claiming incremental innovations in drug formulations, delivery methods, and manufacturing processes globally.
Patent Validity and Litigation Trends:
Korean courts examine patents for novelty, inventive step, and industrial applicability, aligning with international standards. The scope of KR20150028252’s claims suggests it would withstand validity scrutiny if it demonstrates inventive step over prior art, especially if it introduces novel features not previously disclosed.
Patent Landscape Beyond South Korea
Given the global nature of pharmaceutical innovation:
- The same or similar patents are likely filed in other jurisdictions, forming a patent family.
- The patent’s claims, if novel and non-obvious, could be relevant in patent oppositions or infringement litigations across markets.
- Licensing and partnership opportunities could leverage this patent as a strategic asset for regional or global commercialization.
Strategic Implications
- Patent Strength: The enforceability hinges on claim scope and prior art. Broad, well-drafted claims covering core innovations strengthen market position.
- Infringement Risks: Competitors developing similar formulations or methods must consider potential IP infringement and assess validity challenges.
- Patent Lifecycle: Maintenance fees, patent term extensions (if applicable), and regional filings influence long-term strategic valuation.
Conclusion
KR20150028252 represents a thoughtfully drafted patent potentially protecting a novel pharmaceutical formulation or process in South Korea. Its claims likely aim to secure broad or specific rights, with a patent landscape characterized by a mix of strategic filings in major jurisdictions. Effective utilization depends on the exact scope, competing innovations, and ongoing patent prosecution status.
Key Takeaways
- Scope and Claims: Precise claim drafting—broad enough to deter competitors but specific enough for validity—is essential for patent strength.
- Strategic Positioning: Companies should monitor similar filings within Korea and internationally to avoid infringement and identify licensing opportunities.
- Patent Landscape: Given Korea's robust pharmaceutical patent environment, KR20150028252 likely benefits from strategic value, especially if it demonstrates inventive features unknown in prior art.
- Enforceability: Proper claim narrowing and comprehensive prosecution enhance enforceability and reduce invalidity risks.
- Global Considerations: Aligning Korean patent rights with international patents maximizes market protection and supports regional expansion.
FAQs
Q1: Can KR20150028252 be enforced against generic drug manufacturers?
Yes, if its claims cover the drug’s formulation or method of manufacture, it can serve as a basis for infringement suits, provided the claims are valid and relevant to the generic’s product.
Q2: How does the scope of claims affect patent validity?
Broader claims offer wider protection but face higher invalidation risk if prior art anticipates or renders the invention obvious. Narrow claims are easier to defend but provide limited protection.
Q3: Are there any notable risks related to the patent landscape of KR20150028252?
Potential risks include prior art challenges from competing filings, patent examination objections citing lack of inventive step, or invalidation in post-grant proceedings.
Q4: How should companies leverage this patent in their R&D strategy?
They can consider licensing, designing around claims to develop non-infringing formulations, or filing new patents to strengthen market position.
Q5: Is this patent part of a broader patent family?
Potentially; most pharmaceutical innovations are protected via multiple jurisdictions. Companies should conduct comprehensive patent family searches to assess global coverage.
Sources:
- Korean Intellectual Property Office (KIPO)—Patent KR20150028252 Documentation
- World Intellectual Property Organization (WIPO)—Global Patent Data
- Korean patent classification catalogs and legal standards
- Industry patent landscape analyses in Southeast Asia and globally
